{"schemaVersion":"WPF-PUBLIC-UPDATES-1.0","generatedAt":"2026-09-24T03:24:15.672Z","governance":"Only published governed records are included.","counts":{"evidence":50,"regulatory":25,"corrections":0},"evidence":[{"id":"8c103b5a-3fd1-442e-bf9d-fcad7e9c59b0","title":"Thymosin Beta-4 Recombinant Adeno-associated Virus Enhances Human Nucleus Pulposus Cell Proliferation and Reduces Cell Apoptosis and Senescence.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2015,"evidenceTier":"animal","doi":"10.4103/0366-6999.157686","pubmedId":"26021512","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"e1f84f9d-3e4c-4fb3-a5c9-6e97a6cf0a7d","title":"A Novel Combination Therapy Tβ4/VIP Protects against Hyperglycemia-Induced Changes in Human Corneal Epithelial Cells.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2023,"evidenceTier":"animal","doi":"10.3390/bios13110974","pubmedId":"37998149","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"35ee1441-ccb3-4a00-a06f-3565aee224ae","title":"Localization of thymosin beta-4 in tumors.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2007,"evidenceTier":"laboratory","doi":"10.1196/annals.1415.005","pubmedId":"17495241","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"b15304c2-2705-4a88-9c43-78afea1c9cb3","title":"Thymosin Beta-4 Induces Mouse Hair Growth.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2015,"evidenceTier":"animal","doi":"10.1371/journal.pone.0130040","pubmedId":"26083021","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"0aa02f0c-b580-4bc7-a952-f59569678cc9","title":"Expression of thymosin beta-4 in human periodontal ligament cells and mouse periodontal tissue and its role in osteoblastic/cementoblastic differentiation.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2015,"evidenceTier":"animal","doi":"10.1016/j.diff.2015.08.003","pubmedId":"26361868","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"ba187f70-171c-4d99-b112-102d29795c7e","title":"Antimicrobial Effects of Thymosin Beta-4 and Ciprofloxacin Adjunctive Therapy in <i>Pseudomonas aeruginosa</i> Induced Keratitis.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2020,"evidenceTier":"animal","doi":"10.3390/ijms21186840","pubmedId":"32961846","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"698f0f96-72c3-4363-b112-49dd0442b886","title":"Cellular trafficking of thymosin beta-4 in HEPG2 cells following serum starvation.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2013,"evidenceTier":"animal","doi":"10.1371/journal.pone.0067999","pubmedId":"23967050","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"acb7d86e-ea7b-4c85-bc3f-07e3b7487e8b","title":"Expression of thymosin beta-4 and related genes in developing human brain","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":1992,"evidenceTier":"laboratory","doi":"10.1007/bf02919408","pubmedId":"1627460","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"67c950dd-39ba-4799-afbd-5d5794e99706","title":"Thymosin beta-4 overexpression correlates with high-risk groups in gastric gastrointestinal stromal tumors: A retrospective analysis by immunohistochemistry.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2017,"evidenceTier":"observational","doi":"10.1016/j.prp.2017.07.005","pubmedId":"28756979","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"eae8e09c-06bb-43a6-95c1-36e1a964d286","title":"Thymosin Beta-4 Suppresses Osteoclastic Differentiation and Inflammatory Responses in Human Periodontal Ligament Cells.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2016,"evidenceTier":"animal","doi":"10.1371/journal.pone.0146708","pubmedId":"26789270","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"b7ae141c-b867-4ee6-8833-1525352d0e0e","title":"Adjunctive Thymosin Beta-4 Treatment Influences MΦ Effector Cell Function to Improve Disease Outcome in <i>Pseudomonas aeruginosa</i>-Induced Keratitis.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2021,"evidenceTier":"animal","doi":"10.3390/ijms222011016","pubmedId":"34681676","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"b9ea4a90-beb3-48d4-a1c1-71f1a9338afc","title":"Function of Thymosin Beta-4 in Ethanol-Induced Microglial Activation","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2016,"evidenceTier":"animal","doi":"10.1159/000445578","pubmedId":"27189760","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"fc71ef2f-f5c6-4203-9abf-9c61828c236e","title":"Association between Thymosin beta-4, acute kidney injury, and mortality in patients with sepsis: An observational cohort study.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2021,"evidenceTier":"observational","doi":"10.1016/j.intimp.2021.108167","pubmedId":"34607232","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"a7733d90-7405-49d0-813d-2810811744e8","title":"Targeted heart repair by Tβ4-loaded cardiac-resident macrophage-derived extracellular vesicles modified with monocyte membranes.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2023,"evidenceTier":"animal","doi":"10.1016/j.actbio.2023.08.022","pubmedId":"37597679","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"d1652ffe-cb64-428f-9311-55822c252e34","title":"Thymosin beta-4 - A potential tool in healing middle ear lesions in adult mammals.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2023,"evidenceTier":"animal","doi":"10.1016/j.intimp.2023.109830","pubmedId":"38706788","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"8b59c219-d222-4ae5-9bb7-623cb63f7156","title":"Hypoxia/reoxygenation-experienced cancer cell migration and metastasis are regulated by Rap1- and Rac1-GTPase activation via the expression of thymosin beta-4.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2015,"evidenceTier":"animal","doi":"10.18632/oncotarget.3218","pubmedId":"25888632","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"18477114-841d-4ade-b746-5ed29b1ddbae","title":"Thymosin beta-4 regulates activation of hepatic stellate cells via hedgehog signaling.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2017,"evidenceTier":"animal","doi":"10.1038/s41598-017-03782-x","pubmedId":"28630423","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"266f4286-e478-4127-9d59-a0fdc87b613a","title":"Protection of thymosin beta-4 on corneal endothelial cells from UVB-induced apoptosis.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2010,"evidenceTier":"animal","doi":"10.4077/cjp.2010.amh091","pubmedId":"21793328","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"20cffe46-2a8b-4438-b15d-8e3908c02110","title":"Actin-sequestering protein, thymosin beta-4, induces paclitaxel resistance through ROS/HIF-1α stabilization in HeLa human cervical tumor cells","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2010,"evidenceTier":"laboratory","doi":"10.1016/j.lfs.2010.07.002","pubmedId":"20637781","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"4a49c565-6fb3-47d9-9e56-e9b41318f458","title":"Di-(2-ethylhexyl) phthalate-induced tumor growth is regulated by primary cilium formation via the axis of H<sub>2</sub>O<sub>2</sub> production-thymosin beta-4 gene expression.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2021,"evidenceTier":"animal","doi":"10.7150/ijms.53595","pubmedId":"33526986","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"49a89764-b86a-4e47-a85f-b3339ca9167d","title":"Thymosin beta-4 participate in antibacterial immunity and wound healing in black tiger shrimp, Penaeus monodon.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2023,"evidenceTier":"animal","doi":"10.1016/j.fsi.2023.109065","pubmedId":"37689229","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"16a6d29b-fc1f-4ac6-b700-ddf41a643d23","title":"Tβ4-overexpression based on the piggyBac transposon system in cashmere goats alters hair fiber characteristics.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2017,"evidenceTier":"animal","doi":"10.1007/s11248-016-9988-7","pubmedId":"27900536","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"22b4dfdc-276c-49c3-8f0c-d8d21eaae8cb","title":"Thymosin beta-4 directs cell fate determination of human mesenchymal stem cells through biophysical effects.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2010,"evidenceTier":"animal","doi":"10.1002/jor.20956","pubmedId":"19637215","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"8abfafde-b5ab-4eb0-9cc9-48880a98e6d6","title":"Adjunctive Thymosin Beta-4 Treatment Influences PMN Effector Cell Function during <i>Pseudomonas aeruginosa</i>-Induced Corneal Infection.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2021,"evidenceTier":"animal","doi":"10.3390/cells10123579","pubmedId":"34944086","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"852e9929-2d77-4f43-8bb4-3a8f35e8cdbf","title":"Upregulated Tβ4 expression in inflammatory bowel disease impairs the intestinal mucus barrier by inhibiting autophagy in mice.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2024,"evidenceTier":"animal","doi":"10.1016/j.yexcr.2023.113871","pubmedId":"38049080","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"82f6513e-0315-436f-bf94-2964e0d0bf6a","title":"Electrospun thymosin Beta-4 loaded PLGA/PLA nanofiber/ microfiber hybrid yarns for tendon tissue engineering application.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2020,"evidenceTier":"animal","doi":"10.1016/j.msec.2019.110268","pubmedId":"31753373","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"80fea3de-ffe1-4ab0-916a-0b2c7ad8745b","title":"Recombinant human thymosin beta-4 (rhTβ4) improved scalp condition and microbiome homeostasis in seborrheic dermatitis.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2021,"evidenceTier":"animal","doi":"10.1111/1751-7915.13897","pubmedId":"34318587","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"5c0057ca-9f96-492e-b885-d2e08105bf4a","title":"Recombinant Human Thymosin Beta-4 Protects against Mouse Coronavirus Infection.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2021,"evidenceTier":"animal","doi":"10.1155/2021/9979032","pubmedId":"33967626","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"144000a5-79d2-4a01-b540-a59de0f45a06","title":"MALDI-imaging reveals thymosin beta-4 as an independent prognostic marker for colorectal cancer.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2015,"evidenceTier":"animal","doi":"10.18632/oncotarget.6103","pubmedId":"26556858","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"5bdd2f0e-bff1-4f90-a021-f4954011d10d","title":"Mechanistic study of the Tβ4/SLC7A11 signaling pathway regulating breast cancer evolution.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2025,"evidenceTier":"animal","doi":"10.1016/j.cellsig.2025.112111","pubmedId":"40912522","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"d8bc52c1-789f-43f8-8beb-fb297172125a","title":"Thymosin Beta-4 Is Elevated in Women With Heart Failure With Preserved Ejection Fraction.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2017,"evidenceTier":"observational","doi":"10.1161/jaha.117.005586","pubmedId":"28611096","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"b83a01ea-6bf1-4dff-b8af-152793481016","title":"Sources of variability in quantifying circulating thymosin beta-4: literature review and recommendations.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2018,"evidenceTier":"observational","doi":"10.1080/14712598.2018.1448382","pubmedId":"29502471","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"80e1421f-4161-4d6a-926e-0e07e9b8bc42","title":"The Role of Tβ4-POP-Ac-SDKP Axis in Organ Fibrosis.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2022,"evidenceTier":"animal","doi":"10.3390/ijms232113282","pubmedId":"36362069","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"cf1b1d70-18b6-4bcc-bbb1-e7f3c1ea28fd","title":"In vivo growth suppression of CT-26 mouse colorectal cancer cells by adenovirus-expressed small hairpin RNA specifically targeting thymosin beta-4 mRNA.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2014,"evidenceTier":"animal","doi":"10.1038/cgt.2014.43","pubmedId":"25124811","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"705306d9-9771-443e-979c-513b18e49d9c","title":"Thymosin Beta-4 Modulates Cardiac Remodeling by Regulating ROCK1 Expression in Adult Mammals.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2025,"evidenceTier":"animal","doi":"10.3390/ijms26094131","pubmedId":"40362372","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"0a936b30-cd9e-40ac-8dad-88d91019516b","title":"Thymosin beta-4 prenatal administration improves fetal development and halts side effects due to preterm delivery.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2021,"evidenceTier":"animal","doi":"10.26355/eurrev_202101_24411","pubmedId":"33506933","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"f67e4b2f-2359-446a-bc87-e883a0f516bc","title":"A thymosin beta-4 is involved in production of hemocytes and immune defense of Hong Kong oyster, Crassostrea hongkongensis.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2016,"evidenceTier":"animal","doi":"10.1016/j.dci.2015.12.007","pubmedId":"26695126","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"abe8b19e-6653-4501-97c8-f19735688863","title":"No effect of thymosin beta-4 on the expression of the transcription factor Islet-1 in the adult murine heart.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2018,"evidenceTier":"animal","doi":"10.1002/prp2.407","pubmedId":"29864245","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"1bca6202-5207-45d0-b357-15178981a971","title":"Aberrant Expression of Thymosin Beta-4 Correlates With Advanced Disease and BRAF V600E Mutation in Thyroid Cancer.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2022,"evidenceTier":"animal","doi":"10.1369/00221554221138370","pubmedId":"36321670","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"605434c7-5037-4fc2-a911-033b00bd321a","title":"Actin-sequestering protein, thymosin beta-4, is a novel hypoxia responsive regulator.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2010,"evidenceTier":"animal","doi":"10.1007/s10585-010-9350-z","pubmedId":"20821256","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"20b0e8e1-0cdb-43af-848e-7f8e75a49854","title":"Nuclear factor (erythroid-derived 2)-like 2 counter-regulates thymosin beta-4 expression and primary cilium formation for HeLa cervical cancer cell survival.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2022,"evidenceTier":"animal","doi":"10.1038/s41598-022-24596-6","pubmedId":"36424462","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"edc91e5f-208c-4239-9986-f3cba66ae543","title":"Hypoxia-inducible transcription factor (HIF)-1 alpha stabilization by actin-sequestering protein, thymosin beta-4 (TB4) in Hela cervical tumor cells.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2008,"evidenceTier":"animal","doi":"10.1016/j.canlet.2008.01.004","pubmedId":"18272284","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"a27c466d-d39d-4224-bbf6-aa11ac46d465","title":"Tβ4-Engineered ADSC Extracellular Vesicles Rescue Cell Senescence Through Separable Microneedle Patches for Diabetic Wound Healing.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2025,"evidenceTier":"animal","doi":"10.1002/advs.202505009","pubmedId":"40279568","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"066e9d65-2fc8-4f30-a16e-cead3af7a6a3","title":"Tβ4-17 peptide enhances the chemo-sensitivity of ovarian cancer cells to DDP by affecting NF-κB signaling pathway.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2025,"evidenceTier":"animal","doi":"10.1007/s12032-025-03106-4","pubmedId":"41205079","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"0ca935cb-9581-4272-aefb-865790a9985e","title":"Thymosin beta-4 denotes new directions towards developing prosperous anti-aging regenerative therapies.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2023,"evidenceTier":"animal","doi":"10.1016/j.intimp.2023.109741","pubmedId":"36709593","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"c7f0b1cc-e125-4ace-a3ab-a3c3b17e171e","title":"Thymosin beta-4 improves endothelial function and reparative potency of diabetic endothelial cells differentiated from patient induced pluripotent stem cells.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2022,"evidenceTier":"animal","doi":"10.1186/s13287-021-02687-x","pubmedId":"35012642","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"9af36cd8-ac67-4ad0-b498-2b3ebad56e81","title":"Thymosin beta-4 knockdown in IEC-6 normal intestinal epithelial cells induces DNA re-replication via downregulating Emi1.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2014,"evidenceTier":"animal","doi":"10.1002/jcp.24609","pubmedId":"24615569","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"f0cf1555-24c2-4f43-8aa9-ccc5798f7ef1","title":"Thymosin beta-4 promotes mesenchymal stem cell proliferation via an interleukin-8-dependent mechanism.","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2013,"evidenceTier":"animal","doi":"10.1016/j.yexcr.2013.04.014","pubmedId":"23712052","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"2e97f368-07ee-4fc4-bdb2-0c91f91f6a4f","title":"Thymosin beta-4 upregulates anti-oxidative enzymes and protects human cornea epithelial cells against oxidative damage","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":2008,"evidenceTier":"laboratory","doi":"10.1136/bjo.2007.136747","pubmedId":"18480304","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"a3ad7b97-c260-44b8-93fd-50e81075c82f","title":"Possibility of HIV gp41 and thymosin beta-4 sharing the same antigenic epitope","updatedAt":"2026-09-23T23:29:36.593Z","publicationYear":1989,"evidenceTier":"laboratory","doi":"10.1097/00002030-198905000-00013","pubmedId":"2475143","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}}],"regulatory":[{"id":"7f464d98-fe8f-430d-84dd-4197eda703dd","jurisdiction":"United States — FDA","status":"not_approved","updatedAt":"2026-09-23T23:29:36.671Z","sourceTitle":"FDA Drugs@FDA database","sourceUrl":"https://www.accessdata.fda.gov/scripts/cder/daf/","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"00bf38d2-42c0-4a79-82f7-e25ff0a7e339","jurisdiction":"European Union — EMA","status":"not_approved","updatedAt":"2026-09-23T23:29:36.671Z","sourceTitle":"European Medicines Agency medicines database","sourceUrl":"https://www.ema.europa.eu/en/medicines","peptide":{"slug":"thymosin-beta-4","commonName":"Thymosin beta-4"}},{"id":"9462f73a-f08f-4d6a-bfca-e8d7bfef02ff","jurisdiction":"European Union — EMA","status":"not_approved","updatedAt":"2026-09-23T23:29:35.429Z","sourceTitle":"European Medicines Agency medicines database","sourceUrl":"https://www.ema.europa.eu/en/medicines","peptide":{"slug":"pramlintide","commonName":"Pramlintide"}},{"id":"1b174f1d-2079-4f36-8646-b63185b66adb","jurisdiction":"United States — FDA","status":"approved","updatedAt":"2026-09-23T23:29:35.429Z","sourceTitle":"FDA SYMLIN (pramlintide acetate) prescribing information","sourceUrl":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021332s025lbl.pdf","peptide":{"slug":"pramlintide","commonName":"Pramlintide"}},{"id":"e81499ee-f1da-4570-beaa-78087a433012","jurisdiction":"European Union — EMA","status":"not_approved","updatedAt":"2026-09-23T23:29:34.166Z","sourceTitle":"European Medicines Agency medicines database","sourceUrl":"https://www.ema.europa.eu/en/medicines","peptide":{"slug":"pemvidutide","commonName":"Pemvidutide"}},{"id":"368e5069-d525-46ce-bb1f-51374694020d","jurisdiction":"United States — FDA","status":"not_approved","updatedAt":"2026-09-23T23:29:34.166Z","sourceTitle":"FDA Drugs@FDA database","sourceUrl":"https://www.accessdata.fda.gov/scripts/cder/daf/","peptide":{"slug":"pemvidutide","commonName":"Pemvidutide"}},{"id":"98e379e0-c41d-469d-8870-2bb62d3562ea","jurisdiction":"China — NMPA","status":"approved","updatedAt":"2026-09-23T23:29:32.990Z","sourceTitle":"Innovent Announces Mazdutide, First Dual GCG/GLP-1 Receptor Agonist, Received Approval from China's NMPA for Chronic Weight Management","sourceUrl":"https://www.prnewswire.com/news-releases/innovent-announces-mazdutide-first-dual-gcgglp-1-receptor-agonist-received-approval-from-chinas-nmpa-for-chronic-weight-management-302493152.html","peptide":{"slug":"mazdutide","commonName":"Mazdutide"}},{"id":"b82b29e5-6b0e-4718-a3c0-3d7697690157","jurisdiction":"United States — FDA","status":"not_approved","updatedAt":"2026-09-23T23:29:32.990Z","sourceTitle":"FDA Drugs@FDA database","sourceUrl":"https://www.accessdata.fda.gov/scripts/cder/daf/","peptide":{"slug":"mazdutide","commonName":"Mazdutide"}},{"id":"1e365c04-7dd1-44df-9094-8d930872a3bf","jurisdiction":"European Union — EMA","status":"approved","updatedAt":"2026-09-23T23:29:31.762Z","sourceTitle":"European Medicines Agency: Baqsimi (glucagon)","sourceUrl":"https://www.ema.europa.eu/en/medicines/human/EPAR/baqsimi","peptide":{"slug":"glucagon","commonName":"Glucagon"}},{"id":"47960744-793a-4a7a-af94-d83149a998be","jurisdiction":"United States — FDA","status":"approved","updatedAt":"2026-09-23T23:29:31.762Z","sourceTitle":"FDA GlucaGen (glucagon) prescribing information","sourceUrl":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020918s054lbl.pdf","peptide":{"slug":"glucagon","commonName":"Glucagon"}},{"id":"8e7b2ee3-5ed3-418a-b937-069649b0b80b","jurisdiction":"European Union — EMA","status":"not_approved","updatedAt":"2026-09-23T23:29:30.479Z","sourceTitle":"European Medicines Agency medicines database","sourceUrl":"https://www.ema.europa.eu/en/medicines","peptide":{"slug":"humanin","commonName":"Humanin"}},{"id":"721a0587-b36b-440b-952b-5c6ff04d2cba","jurisdiction":"United States — FDA","status":"not_approved","updatedAt":"2026-09-23T23:29:30.479Z","sourceTitle":"FDA Drugs@FDA database","sourceUrl":"https://www.accessdata.fda.gov/scripts/cder/daf/","peptide":{"slug":"humanin","commonName":"Humanin"}},{"id":"53cbba17-290e-4b3f-a6a3-d6c6f12a34b8","jurisdiction":"European Union — EMA","status":"not_approved","updatedAt":"2026-09-23T23:29:29.220Z","sourceTitle":"European Medicines Agency medicines database","sourceUrl":"https://www.ema.europa.eu/en/medicines","peptide":{"slug":"cagrilintide","commonName":"Cagrilintide"}},{"id":"27e5d727-b171-48cd-b4c2-a5c703b871e9","jurisdiction":"United States — FDA","status":"not_approved","updatedAt":"2026-09-23T23:29:29.220Z","sourceTitle":"FDA Drugs@FDA database","sourceUrl":"https://www.accessdata.fda.gov/scripts/cder/daf/","peptide":{"slug":"cagrilintide","commonName":"Cagrilintide"}},{"id":"a9667ef7-173b-45fd-b8ea-944a9678a318","jurisdiction":"European Union — EMA","status":"approved","updatedAt":"2026-09-23T23:29:27.991Z","sourceTitle":"European Medicines Agency: Prialt (ziconotide)","sourceUrl":"https://www.ema.europa.eu/en/medicines/human/EPAR/prialt","peptide":{"slug":"ziconotide","commonName":"Ziconotide"}},{"id":"f797e8d2-c205-4ac8-94c4-f6c27022e863","jurisdiction":"United States — FDA","status":"approved","updatedAt":"2026-09-23T23:29:27.991Z","sourceTitle":"FDA PRIALT (ziconotide) prescribing information","sourceUrl":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021060s003lbl.pdf","peptide":{"slug":"ziconotide","commonName":"Ziconotide"}},{"id":"aa739181-10f8-4aa1-a7af-13c6931ef661","jurisdiction":"European Union — EMA","status":"approved","updatedAt":"2026-09-23T23:29:26.743Z","sourceTitle":"European Medicines Agency: Revestive (teduglutide)","sourceUrl":"https://www.ema.europa.eu/en/medicines/human/EPAR/revestive","peptide":{"slug":"teduglutide","commonName":"Teduglutide"}},{"id":"a5dea127-3a97-453a-bf8c-343317bcdfa5","jurisdiction":"United States — FDA","status":"approved","updatedAt":"2026-09-23T23:29:26.743Z","sourceTitle":"FDA GATTEX (teduglutide) prescribing information","sourceUrl":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/203441s022lbl.pdf","peptide":{"slug":"teduglutide","commonName":"Teduglutide"}},{"id":"d41e0d0f-b670-49f5-a3be-e1a90f7edec8","jurisdiction":"European Union — EMA","status":"approved","updatedAt":"2026-09-23T23:29:25.447Z","sourceTitle":"European Medicines Agency: Constella (linaclotide)","sourceUrl":"https://www.ema.europa.eu/en/medicines/human/EPAR/constella","peptide":{"slug":"linaclotide","commonName":"Linaclotide"}},{"id":"d34e974e-7196-4a68-b878-89935e91e14e","jurisdiction":"United States — FDA","status":"approved","updatedAt":"2026-09-23T23:29:25.447Z","sourceTitle":"FDA LINZESS (linaclotide) prescribing information","sourceUrl":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/202811s022lbl.pdf","peptide":{"slug":"linaclotide","commonName":"Linaclotide"}},{"id":"0cc95154-75db-496c-b717-50c791f0fd12","jurisdiction":"United States — FDA","status":"not_approved","updatedAt":"2026-09-23T23:29:23.900Z","sourceTitle":"FDA Drugs@FDA database","sourceUrl":"https://www.accessdata.fda.gov/scripts/cder/daf/","peptide":{"slug":"kisspeptin","commonName":"Kisspeptin"}},{"id":"71d8a989-fd70-4fec-81fd-34e2bd21508d","jurisdiction":"European Union — EMA","status":"not_approved","updatedAt":"2026-09-23T23:29:23.900Z","sourceTitle":"European Medicines Agency medicines database","sourceUrl":"https://www.ema.europa.eu/en/medicines","peptide":{"slug":"kisspeptin","commonName":"Kisspeptin"}},{"id":"35978346-76a0-48cd-9416-5da6f59bc6cf","jurisdiction":"United States — FDA","status":"approved","updatedAt":"2026-09-23T23:29:22.653Z","sourceTitle":"FDA VYLEESI (bremelanotide injection) prescribing information","sourceUrl":"https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210557s000lbl.pdf","peptide":{"slug":"bremelanotide","commonName":"Bremelanotide"}},{"id":"c29f5165-0311-4f06-8bec-418a96ee40e8","jurisdiction":"European Union — EMA","status":"not_approved","updatedAt":"2026-09-23T23:29:22.653Z","sourceTitle":"European Medicines Agency medicines database","sourceUrl":"https://www.ema.europa.eu/en/medicines","peptide":{"slug":"bremelanotide","commonName":"Bremelanotide"}},{"id":"c8730324-23d5-417e-af3c-6aad11e3beea","jurisdiction":"United States — FDA","status":"approved","updatedAt":"2026-09-23T23:29:20.694Z","sourceTitle":"FDA Orphan Drug Designations and Approvals: afamelanotide / SCENESSE","sourceUrl":"https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=263208","peptide":{"slug":"afamelanotide","commonName":"Afamelanotide"}}],"corrections":[]}